Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Placenta-derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs

29 Dec 2010

Abstract excerpt

Over the past few years, mesenchymal stem cells (MSCs) have become of increasing interest for use in the field of regenerative medicine. To date, bone marrow (BM) has been the main source of MSCs (BM-MSCs) for both experimental and clinical studies. However, the use of MSCs derived from BM can be problematic, due to the low number of MSCs found in bone marrow aspirates and the invasive procedure associated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mesenchymal stem cell research
Share to Organ and Tissue Transplantation Research
Share to Periodontal Regeneration and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21953866
DOI: 10.1002/term.362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Placenta-derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCsPMID 21953866Read ↗

Human Mesenchymal Stromal Cells from Adult and Neonatal Sources: A Comparative In Vitro Analysis of Their Immunosuppressive Properties Against T CellsSemantic proximity Read ↗

Isolation and characterisation of mesenchymal stem cells derived from human placenta tissueSemantic proximity Read ↗

Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem CellsSemantic proximity Read ↗

Distinct biological characteristics of mesenchymal stem cells separated from different components of human placentaSemantic proximity Read ↗

How far are we from the clinical use of placental-derived mesenchymal stem cells?Semantic proximity Read ↗

Toward Cell Therapy Using Placenta-Derived Cells: Disease Mechanisms, Cell Biology, Preclinical Studies, and Regulatory Aspects at the Round TableSemantic proximity Read ↗

Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiationSemantic proximity Read ↗

Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical CordSemantic proximity Read ↗

Novel Immunomodulatory Markers Expressed by Human WJ-MSC: an Updated Review in Regenerative and Reparative MedicineSemantic proximity Read ↗

Phenotypic and Functional Characterization of Mesenchymal Stem/Multipotent Stromal Cells from<i>Decidua Basalis</i>of Human Term PlacentaSemantic proximity Read ↗

Different characteristics of mesenchymal stem cells isolated from different layers of full term placentaSemantic proximity Read ↗

A comparison of isolation and culture protocols for human amniotic mesenchymal stem cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.